NCT00234949View on ClinicalTrials.gov

A Study to Compare Cefdinir and Cephalexin for the Treatment of Mild to Moderate Uncomplicated Skin Infections

PHASE4CompletedINTERVENTIONAL
Enrollment

380

Participants

Timeline

Start Date

March 31, 2005

Conditions
Mild to Moderate Uncomplicated Skin and Skin Structure Infections
Interventions
DRUG

cefdinir

DRUG

cephalexin

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY